- Investing Ideas
- Swedish Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Swedish Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
5
Value score of at least 4 focused on companies with a low market cap.
5 companies
Sprint Bioscience
Market Cap: SEK 386.2m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 3.66
7D
46.4%
1Y
470.1%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%
Level Bio
Market Cap: SEK 20.0m
Manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally.
LEVBIO
SEK 0.29
7D
3.6%
1Y
-25.6%
Guard Therapeutics International
Market Cap: SEK 24.2m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.20
7D
-11.8%
1Y
-90.2%
Subgen AI
Market Cap: SEK 128.3m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.13
7D
-21.7%
1Y
n/a